v3.25.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Total Dentsply Sirona Equity
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interests
Beginning Balance at Dec. 31, 2023 $ 3,294 $ 3,293 $ 3 $ 6,643 $ 205 $ (636) $ (2,922) $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 17 18     18     (1)
Other comprehensive (loss) income (30) (30)       (30)    
Stock-based compensation expense 11 11   11        
Funding of employee stock purchase plan 3 3         3  
Restricted stock unit distributions (4) (4)   (15)     11  
Cash dividends (33) (33)     (33)      
Ending Balance at Mar. 31, 2024 3,258 3,258 3 6,639 190 (666) (2,908) 0
Beginning Balance at Dec. 31, 2023 3,294 3,293 3 6,643 205 (636) (2,922) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 13              
Other comprehensive (loss) income (41)              
Ending Balance at Jun. 30, 2024 3,064 3,064 3 6,631 152 (677) (3,045) 0
Beginning Balance at Mar. 31, 2024 3,258 3,258 3 6,639 190 (666) (2,908) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (4) (4)     (4)      
Other comprehensive (loss) income (11) (11)       (11)    
Stock-based compensation expense 12 12   12        
Treasury shares purchased (152) (152)         (152)  
Restricted stock unit distributions (5) (5)   (20)     15  
Cash dividends (34) (34)     (34)      
Ending Balance at Jun. 30, 2024 3,064 3,064 3 6,631 152 (677) (3,045) 0
Beginning Balance at Dec. 31, 2024 1,943 1,942 3 6,640 (835) (730) (3,136) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 19 20     20     (1)
Other comprehensive (loss) income 71 71       71    
Stock-based compensation expense 10 10   10        
Funding of employee stock purchase plan 2 2   (3)     5  
Restricted stock unit distributions (3) (3)   (17)     14  
Restricted stock unit dividends 0     1 (1)      
Cash dividends (32) (32)     (32)      
Ending Balance at Mar. 31, 2025 2,010 2,010 3 6,631 (848) (659) (3,117) 0
Beginning Balance at Dec. 31, 2024 1,943 1,942 3 6,640 (835) (730) (3,136) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (25)              
Other comprehensive (loss) income 89              
Ending Balance at Jun. 30, 2025 1,961 1,960 3 6,638 (925) (641) (3,115) 1
Beginning Balance at Mar. 31, 2025 2,010 2,010 3 6,631 (848) (659) (3,117) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (44) (45)     (45)     1
Other comprehensive (loss) income 18 18       18    
Stock-based compensation expense 9 9   9        
Restricted stock unit distributions 0 0   (2)     2  
Cash dividends (32) (32)     (32)      
Ending Balance at Jun. 30, 2025 $ 1,961 $ 1,960 $ 3 $ 6,638 $ (925) $ (641) $ (3,115) $ 1